Findings
tumor
TUMOR
In this economic evaluation of a randomized clinical trial including 305 patients, robot-assisted surgery was associated with reductions in admissions to intensive care and readmissions to hospital but increases in theater time. Robot-assisted cystectomy has an incremental cost-effectiveness ratio of £100 008 (US $144 312) per quality-adjusted life-year gained, but subgroups defined by age, tumor stage, and performance status have much higher probabilities of being cost-effective.